A study to observe and record health related and disease related parameters of the children who prospectively receiving treatment for Chronic Myeloid Leukemia (CML)(a type of blood cancer), also considering to study the results of interruption of the chemotherapy in these patients.
Not Applicable
- Conditions
- Health Condition 1: C921- Chronic myeloid leukemia, BCR/ABL-positive
- Registration Number
- CTRI/2020/03/023699
- Lead Sponsor
- Tata Memorial Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Patients with Age <15 years.
2. Diagnosis of CML (Ph positive).
Exclusion Criteria
1. Non-CML myeloproliferation
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1) On study prospective follow-up of patients with CML improves control of disease and <br/ ><br>ensures timely interventions to tackle suboptimal response. <br/ ><br>2) Stopping TKI in children with good response is possible and majority of them should <br/ ><br>sustain their molecular response despite stoppage of TKITimepoint: At baseline and on every 4 monthly OPD follow-up (as per standard of care)
- Secondary Outcome Measures
Name Time Method ATimepoint: NA